ResearcherMayo ClinicNo recent work listed
Kouros Owzar
Matched on ORCID iD 0000-0002-3340-1287; OpenAlex author ID A5031078301; NIH RePORTER profile ID 9680767. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 3, last author 1)
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 31
2012: 2 papers · 2013: none · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: 2 papers · 2019: 1 paper, 1 grant
Papers 7
- An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance). Last author DOI 10.1097/fpc.0000000000000375↗
- Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk. Co-author DOI 10.1002/ijc.31171↗
- The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation. First author DOI 10.1371/journal.pone.0202272↗
- Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/ng.3052↗
- 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). First author DOI 10.1093/jnci/dju185↗
- Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 8030… Co-author DOI 10.1002/cncr.26270↗
- A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. First author DOI 10.1158/1078-0432.ccr-11-1387↗
Grants 1
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marie Davidian · 1 shared grant, 2019 · strength 0.32
- Michael R Kosorok · 1 shared grant, 2019 · strength 0.32
- Chen Jiang · 5 shared papers, 2012–2019 · strength 0.23
- Paper An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 … DOI 10.1097/fpc.0000000000000375↗
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). DOI 10.1093/jnci/dju185↗
- Hedy Lee Kindler · 5 shared papers, 2012–2019 · strength 0.23
- Paper An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 … DOI 10.1097/fpc.0000000000000375↗
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). DOI 10.1093/jnci/dju185↗
- Federico Innocenti · 4 shared papers, 2012–2019 · strength 0.20
- Paper An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 … DOI 10.1097/fpc.0000000000000375↗
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). DOI 10.1093/jnci/dju185↗
- Herbert I. Hurwitz · 3 shared papers, 2012–2019 · strength 0.17
- Paper An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 … DOI 10.1097/fpc.0000000000000375↗
- Paper Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk. DOI 10.1002/ijc.31171↗
- Paper A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 803… DOI 10.1158/1078-0432.ccr-11-1387↗
- Mark J. Ratain · 3 shared papers, 2012–2019 · strength 0.16
- Paper An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 … DOI 10.1097/fpc.0000000000000375↗
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 803… DOI 10.1158/1078-0432.ccr-11-1387↗
- Alan Paul Venook · 3 shared papers, 2012–2018 · strength 0.13
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). DOI 10.1093/jnci/dju185↗
- Paper Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3… DOI 10.1002/cncr.26270↗
- Katherine Van Loon · 2 shared papers, 2014–2018 · strength 0.10
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). DOI 10.1093/jnci/dju185↗
- Yusuke Nakamura · 2 shared papers, 2012–2018 · strength 0.08
- Paper The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experiment… DOI 10.1371/journal.pone.0202272↗
- Paper A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 803… DOI 10.1158/1078-0432.ccr-11-1387↗
- Andrew B. Nixon · 1 shared paper, 2019 · strength 0.08
- James L. Abbruzzese · 1 shared paper, 2018 · strength 0.07
- Bensong Duan · 1 shared paper, 2018 · strength 0.07
- Qingyi Wei · 1 shared paper, 2018 · strength 0.07
- Hengjun Gao · 1 shared paper, 2018 · strength 0.07
- Hongyu Li · 1 shared paper, 2018 · strength 0.07
- Eileen Mary O'Reilly · 2 shared papers, 2012–2014 · strength 0.07
- Nicole F. Neel · 1 shared paper, 2018 · strength 0.06
- Marina Talamonti · 1 shared paper, 2018 · strength 0.06
- David J. Bentrem · 1 shared paper, 2018 · strength 0.06
- Jen Jen Yeh · 1 shared paper, 2018 · strength 0.06
- Gloria M. Petersen · 1 shared paper, 2018 · strength 0.06
- Robert R. McWilliams · 1 shared paper, 2018 · strength 0.06
- Richard M. Goldberg · 2 shared papers, 2012 · strength 0.05
- Paper Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3… DOI 10.1002/cncr.26270↗
- Paper A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 803… DOI 10.1158/1078-0432.ccr-11-1387↗
- Charles S. Fuchs · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.